Vol. XVIII · Free shipping $75+ · Read the collection
Feature · Product Review
iv glutathione cancer

iv glutathione cancer responsive nanomedicine leverages tumor redox imbalance for targeted theranostics | Discover Oncology IV Nutrient Therapy for Cancer

IV Nutrient Therapy for Cancer Patients Benefits, Evidence and Integrative Approaches Integrative Cancer Care, London & UK Wide 6 health benefits of glutathione What do cancer cells eat? New research reveals surprising fuel source Glutathione: Lights and Shadows in Cancer Patients

SKU: 25106594917 · From www.marsberger-treibhaus.de

4.7
USD21.36 USD70.36

Pay in 4 interest-free payments of $5.34 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Aug 7 - Aug 12

Description

After discovering that the induction of IGF-1 production activates a pathway related to chemotherapy resistance (PIK3/AKT) and transportation to lactate from inside the cell outside, favoring tumor growth, researches have tried to develop strategies to overcome this issue, by simple starvation (72 h fasting prior to chemotherapy) or through starvation mimetics (nutraceuticals, for example), which are the compound that blocks this pathway or others related to, as the SGLT-2, reducing glucose uptake by cancer cells (283, 284)

iv glutathione cancer responsive nanomedicine leverages tumor redox imbalance for targeted theranostics | Discover Oncology IV Nutrient Therapy for Cancer

Jan 2014;142(1):20-26

iv glutathione cancer responsive nanomedicine leverages tumor redox imbalance for targeted theranostics | Discover Oncology IV Nutrient Therapy for Cancer

Node-level metabolitemetabolite network topology metrics, including degree and betweenness centrality for pre- and post-GF-MKD samples, are provided in Supplementary Table S6

iv glutathione cancer responsive nanomedicine leverages tumor redox imbalance for targeted theranostics | Discover Oncology IV Nutrient Therapy for Cancer

Accordingly, serine deprivation or SSP blockade restores the sensitivity of colorectal cancer cells to 5-FU ( 6.2.2 Targeted therapy resistance 6.2.2.1 BRAF inhibitor resistance Proteomic analysis of acquired-resistance cell lines revealed altered expression of serine biosynthetic enzymes (PHGDH, PSPH, PSAT1) in drug-resistant cells

iv glutathione cancer responsive nanomedicine leverages tumor redox imbalance for targeted theranostics | Discover Oncology IV Nutrient Therapy for Cancer
Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

GHK Cu

US$ 20.50

4.4 (24 reviews)

Frontiers

US$ 21.02

4.5 (6 reviews)

recommand products